Join us as we speak with Charles Huang and Dr. Gabriel Mannis in honor of AML Awareness Day (April 21st). In this episode, Charles tells us about his treatment for AML, participation in clinical trials, and shares about his struggle to find a bone marrow donor as an Asian Pacific Islander. Charles then turned his struggle into legislation to make it easier to join a bone marrow donor registry to save lives. Dr. Mannis, of Stanford Medicine, shares about the latest advances in AML research, from clinical trials in Chimeric Antigen Receptor (CAR) therapy to medications that reduce graft-vs-host disease (GVHD). With research advancing quickly in the field of AML treatment, patients and caregivers are given reasons to have hope after the uncertainty of a diagnosis.

Mentioned on this episode: 

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes (MDS)
• Minimal/Measurable Residual Disease
• CAR T-cell Therapy
• Stem Cell Transplant
• Graft-Vs-Host-Disease (GVHD)
• Charlie’s Law
• Be The Match – Bone Marrow Donor Registry
• LLS Advocacy & Public Policy
• Innovative Therapies in Acute Leukemias podcast episode

Additional LLS Support Resources: 

• Information Specialists
• Free telephone/web patient programs 
• Clinical Trial Support Center
• Free booklets 
• Financial support
• Online chats 
• Caregiver support 
• LLS Community 
• Support groups 
• Free Nutrition Consultations 
• LLS Myeloma Link
• Patti Robinson Kaufmann First Connection Program 
• Young Adult Resources
• Survivorship Workbook

Support for this episode provided by Astellas and Genentech, Inc & Biogen.

The post Patient-Doctor Perspectives: Hope in the Uncertainty of AML first appeared on The Bloodline with Blood Cancer United Podcast.